SE8103003L - Terapeutisk forfarande for behandling av diabetes och farmaceutisk komposition for genomforande av forfarandet - Google Patents
Terapeutisk forfarande for behandling av diabetes och farmaceutisk komposition for genomforande av forfarandetInfo
- Publication number
- SE8103003L SE8103003L SE8103003A SE8103003A SE8103003L SE 8103003 L SE8103003 L SE 8103003L SE 8103003 A SE8103003 A SE 8103003A SE 8103003 A SE8103003 A SE 8103003A SE 8103003 L SE8103003 L SE 8103003L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- carnitine
- implementation
- pharmaceutical composition
- treating diabetes
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 206010010071 Coma Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 206010023379 Ketoacidosis Diseases 0.000 abstract 1
- 208000007976 Ketosis Diseases 0.000 abstract 1
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- -1 acyl L-carnitines Chemical class 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT48692/80A IT1133010B (it) | 1980-05-15 | 1980-05-15 | Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8103003L true SE8103003L (sv) | 1981-11-16 |
Family
ID=11268073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8103003A SE8103003L (sv) | 1980-05-15 | 1981-05-13 | Terapeutisk forfarande for behandling av diabetes och farmaceutisk komposition for genomforande av forfarandet |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4362719A (sv) |
| JP (1) | JPS579721A (sv) |
| AU (1) | AU540859B2 (sv) |
| BE (1) | BE888797A (sv) |
| CA (1) | CA1173749A (sv) |
| CH (1) | CH654208A5 (sv) |
| DE (1) | DE3119460A1 (sv) |
| FR (1) | FR2482588B1 (sv) |
| GB (1) | GB2075838B (sv) |
| IE (1) | IE51224B1 (sv) |
| IL (1) | IL62847A (sv) |
| IT (1) | IT1133010B (sv) |
| NL (1) | NL8102384A (sv) |
| SE (1) | SE8103003L (sv) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
| IT1237343B (it) * | 1984-03-28 | 1993-05-31 | Francia Farma | Dicloridrato di acetildicarnitina, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono |
| US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5545412A (en) * | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
| US4731360A (en) * | 1985-08-16 | 1988-03-15 | Merck & Co., Inc. | Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments |
| DE3635864A1 (de) * | 1986-06-26 | 1988-05-05 | Gerhard Gergely | Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung |
| US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
| IL99699A (en) * | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
| US5321009A (en) * | 1991-04-03 | 1994-06-14 | American Home Products Corporation | Method of treating diabetes |
| US5420108A (en) * | 1992-09-14 | 1995-05-30 | Shohet; Isaac H. | Method of controlling diabetes mellitus |
| US6046232A (en) * | 1997-10-17 | 2000-04-04 | Centaur Pharmaceuticals, Inc. | α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same |
| IT1306178B1 (it) * | 1999-07-27 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da |
| US6835754B2 (en) | 2001-01-08 | 2004-12-28 | Renovis, Inc. | Use of aryl nitrone compounds in methods for treating neuropathic pain |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| ITRM20040327A1 (it) * | 2004-07-01 | 2004-10-01 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici. |
| RU2324479C2 (ru) * | 2006-07-11 | 2008-05-20 | Денис Владимирович Сидько | Способ комплексной инфузионной терапии у больных с гипергликемической кетоацидотической диабетической комой |
| EP2162127A1 (en) * | 2007-05-24 | 2010-03-17 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists |
| CN107121540B (zh) * | 2016-02-24 | 2020-06-12 | 中国科学院上海营养与健康研究所 | 酰基肉碱谱或其检测试剂在2型糖尿病发病风险预测中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3624887A (en) * | 1970-03-02 | 1971-12-07 | Bunker Ramo | Pin and socket removal tool |
| US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
| JPS5058213A (sv) * | 1973-09-26 | 1975-05-21 | ||
| FR2414914A1 (fr) * | 1978-01-18 | 1979-08-17 | Sigma Tau Ind Farmaceuti | Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine |
-
1980
- 1980-05-15 IT IT48692/80A patent/IT1133010B/it active
-
1981
- 1981-05-07 IE IE1011/81A patent/IE51224B1/en not_active IP Right Cessation
- 1981-05-12 IL IL62847A patent/IL62847A/xx not_active IP Right Cessation
- 1981-05-12 GB GB8114456A patent/GB2075838B/en not_active Expired
- 1981-05-12 AU AU70486/81A patent/AU540859B2/en not_active Expired
- 1981-05-13 CA CA000377523A patent/CA1173749A/en not_active Expired
- 1981-05-13 SE SE8103003A patent/SE8103003L/sv unknown
- 1981-05-14 NL NL8102384A patent/NL8102384A/nl not_active Application Discontinuation
- 1981-05-14 CH CH3155/81A patent/CH654208A5/it not_active IP Right Cessation
- 1981-05-14 BE BE0/204781A patent/BE888797A/fr not_active IP Right Cessation
- 1981-05-15 FR FR8109780A patent/FR2482588B1/fr not_active Expired
- 1981-05-15 US US06/264,044 patent/US4362719A/en not_active Expired - Lifetime
- 1981-05-15 DE DE19813119460 patent/DE3119460A1/de not_active Ceased
- 1981-05-15 JP JP7407781A patent/JPS579721A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL8102384A (nl) | 1981-12-01 |
| FR2482588A1 (fr) | 1981-11-20 |
| IL62847A0 (en) | 1981-07-31 |
| CH654208A5 (it) | 1986-02-14 |
| IE51224B1 (en) | 1986-11-12 |
| FR2482588B1 (fr) | 1986-03-07 |
| JPS579721A (en) | 1982-01-19 |
| AU7048681A (en) | 1981-11-26 |
| CA1173749A (en) | 1984-09-04 |
| DE3119460A1 (de) | 1982-03-04 |
| US4362719A (en) | 1982-12-07 |
| BE888797A (fr) | 1981-08-28 |
| GB2075838A (en) | 1981-11-25 |
| IT1133010B (it) | 1986-07-09 |
| IT8048692A0 (it) | 1980-05-15 |
| IL62847A (en) | 1985-01-31 |
| IE811011L (en) | 1981-11-15 |
| GB2075838B (en) | 1984-05-10 |
| AU540859B2 (en) | 1984-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8103003L (sv) | Terapeutisk forfarande for behandling av diabetes och farmaceutisk komposition for genomforande av forfarandet | |
| NO931267L (no) | Fremgangsmaate for behandling eller forebyggelse av type 1diabetes ved oral administrering av insulin | |
| Crosby | The rationale for treating iron deficiency anemia | |
| ATE70439T1 (de) | Verwendung von acetyl-l-carnitin zur herstellung eines medikamentes zur therapeutischen behandlung von peripheren neuropathien. | |
| DE3468323D1 (en) | Pharmaceutical formulation for the treatment of diabetes mellitus | |
| MX9203543A (es) | Medicamento. | |
| KR920000324A (ko) | 필수 지방산 처리법 | |
| IE790951L (en) | Carnitine solution | |
| ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
| KR880013555A (ko) | 당뇨병의 치료방법 | |
| DE3162614D1 (en) | Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same | |
| SE8500996D0 (sv) | Method of treatment | |
| JPS57126420A (en) | Drug for digestive organ | |
| RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
| KR920702225A (ko) | 약학 조성물 | |
| US5114963A (en) | Method of reducing serum levels of lipoprotein(A) | |
| KR900700102A (ko) | 심장질환 치료에 쓰이는 프로파페논과 퀴니딘의 지속성 조성물 | |
| SU606242A1 (ru) | Антилепрозное средство "димоцифон" | |
| KR930019207A (ko) | 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도 | |
| JPS5569510A (en) | Carcinostatic agent | |
| Friedman et al. | Renal excretion of digitoxin as an indicator of (1) adequate and (2) excessive digitalization | |
| KR870009722A (ko) | 지방 및 탄수화물 대사조절에서의 엔프로스틸형 프로스타글란딘의 용도 | |
| Schottstaedt et al. | Natural history and course of malignant hypertension | |
| DK601788D0 (da) | Anvendelse af antibiotikaene ll-e19020alfa og ll-e19020beta til behandling af visse fjerkraesygdomme | |
| Perry et al. | Dr. Perry and Associates Reply |